- Home
- ESQ vs FTH Comparison
ESQ vs FTH Comparison
Compare ESQ & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESQ | FTH |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 941.0M | 860.0M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ESQ | FTH |
|---|---|---|
| Price | $127.62 | $29.62 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $120.33 | N/A |
| AVG Volume (30 Days) | 132.4K | ★ 242.4K |
| Earning Date | 04-23-2026 | N/A |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | ★ 14.20 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $35.15 | N/A |
| Revenue Next Year | $39.09 | N/A |
| P/E Ratio | $86.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $90.57 | $17.50 |
| 52 Week High | $125.85 | $37.90 |
Technical Indicators
Market Signals| Indicator | ESQ | FTH |
|---|---|---|
| Relative Strength Index (RSI) | 64.79 | 57.90 |
| Support Level | $103.79 | $22.06 |
| Resistance Level | N/A | $37.90 |
| Average True Range (ATR) | 3.74 | 4.04 |
| MACD | 0.01 | -0.19 |
| Stochastic Oscillator | 93.57 | 41.21 |
Price Performance
Historical ComparisonAbout ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.
About FTH Faeth Therapeutics Inc. Common Stock
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.